The Pioneering and Leading Psychedelic Research Conference in Europe

Why Attend ICPR 2022?

ICPR features world-leading experts from many academic disciplines, including psychiatry, psychology, neuroscience, anthropology, ethnobotany, and philosophy who come together to give a scientific conference for academics, therapists, researchers, clinicians, policymakers, and members of the public. The OPEN Foundation has been organising 5 large and international conferences since 2010.

About ICPR 2022

Who attends ICPR?

ICPR is a scientific conference for academics, researchers, clinicians, therapists, healthcare providers, policymakers, entrepreneurs, and members of the public.

Why attend ICPR?

ICPR features world’s leading experts in psychedelic research and therapies from across many fields, including psychiatry, neuroscience, psychology, and anthropology.

What's unique at ICPR?

ICPR is a podium for a wide variety of ideas, disciplines, perspectives, localities, individuals, and communities involved in advancing psychedelic research and therapies.

ICPR 2022: Psychedelic Science, Ethics & Business

Go beyond the science and learn how trials are translated into psychedelic treatments.

Join us for an additional stand-alone day of ICPR on Wednesday the 21st of September focused on the implementation of psychedelics.

The most recent ICPR 2022 updates


Meet the official partner organisations for ICPR 2022

ICPR is organised by the OPEN Foundation, a non-profit organisation […]

Read More

Meet Haarlem: the ‘Little Amsterdam’ where ICPR 2022 will take place

ICPR 2022 will be held in a beautiful building in […]

Read More

Is visiting this psychedelic conference – ICPR 2022 – worth the trip?

ICPR has been a well-respected scientific conference for over 15 […]

Read More

ICPR 2022 Confirmed Speakers

Katrin Preller

Senior Researcher, Psychologist, and Neuroscientist at Yale University / University of Zurich, Switzerland

David Nichols

Founding President of the Heffter Research Institute / Professor Emeritus of Chemistry at Purdue University, United States

Kim Kuypers

Associate Professor at Faculty of Psychology and Neuroscience at Maastricht University, The Netherlands

Rick Doblin

Founder and Executive Director of MAPS, the Multidisciplinary Association for Psychedelic Studies, United States

Amanda Feilding

Founder and Executive Director of the Beckley Foundation, United Kingdom

David Nutt

Professor of Neuropsychopharmacology and head of the Neuropsychopharmacology Unit in the Division of Brain Sciences, Department of Medicine, Imperial College London

Erika Dyck

Professor and Canada Research Chair in the History of Health & Social Justice at the University of Saskatchewan

Roland Griffiths

Professor in the Departments of Psychiatry and Neurosciences at the Johns Hopkins University, United States

Gitte Moos Knudsen

Chair, Professor at Dept. Neurology and Neurobiology Research Unit, Copenhagen University Hospital, Denmark

Paul Stamets

Founder of Fungi Perfecti and CEO of MycoMedica Life Sciences PBC, United States

Friederike Holze

Postdoctoral researcher at University Hospital Basel, Switzerland

Peter Gasser

Psychiatrist and Psychotherapist / President of Swiss Medical Society for Psycholytic Therapy, Switzerland

Janis Phelps

Director of the CIIS: California Institute of Integral Studies, United States

Mendel Kaelen

Founder and CEO at Wavepaths, United Kingdom

Monnica Williams

Research Chair for Mental Health Disparities, University of Ottawa. Principal Investigator for a multi-site study on MDMA-assisted psychotherapy for PTSD, Canada

Bernardo Kastrup

Executive Director of Essentia Foundation / Author, Philosopher, Computer Scientist, the Netherlands

Sonya Faber

Partner at Bioville Gmbh & MSL at Angelini Pharma. BoD member at Chacruna Institute, United States

Matthias Liechti

Professor for clinical pharmacology and internal medicine at the University Hospital Basel, Switzerland

Torsten Passie

Professor of Psychiatry and Psychotherapy at Hannover Medical School, Germany

Charles Raison

Director of Clinical and Translational Research for Usona Institute. Director of Research on Spiritual Health for Emory Healthcare, United States

Bill Richards

Professor psychologist at Johns Hopkins Center for Psychedelic and Consciousness Research, United States
Testimonials from Speakers & Attendees

Why People Love Attending ICPR

Get Your ICPR 2022 Ticket Now

Organisations Supporting Our Nonprofit Mission

ICPR 2022 Partners




Academic Allies

Other Partners

Interested in becoming an official partner of ICPR 2022?
Please apply by clicking the button below.

Ready To Attend ICPR 2022?​

Join the leading conference in Europe dedicated to advancing psychedelic research and therapies.

Want The Latest Updates?

Subscribe below to ICPR Newsletter and get all the latest updates, including discount tickets!

By clicking subscribe, I confirm to receive emails from the OPEN Foundation and agree with its privacy & terms.